NPI registry status
Active
2026 NPPES data Radiation Oncology Physician NPI 1629158340 M.D.
Verify on CMS → Edward Greenleaf, M.D.
Radiation Oncology Physician in Stockton, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,141 in Radiation Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
294
Medicare Part D claims · 79 beneficiaries · Radiation Oncology Physician avg: 135
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$30.79
2 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Edward Greenleaf, M.D. filed 294 Medicare Part D claims in 2024 as a Radiation Oncology Physician in Stockton, California, prescribing 93% generic.
- 294
- Part D claims, 2024
- 93%
- generic prescribing
- $30.79
- industry payments (Sunshine Act)
- ≥48th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Edward Greenleaf, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1629158340), first enumerated 10/17/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 294 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$30.79 in reported industry payments (2 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
California statewide board action statistics are published annually — these figures describe aggregate state activity, not Edward Greenleaf, M.D.'s individual license status. Verify directly with the state medical board.
Source: MBC annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1629158340 · Radiation Oncology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-LIGHT · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1629158340
- ENUM-LEGACY 2006
- TAX-MID 6K Radiation Oncology
- RX-LIGHT 294
- BOOK-LIGHT 643 in California
- PHOTO-ENUM Richard Seither · 2006
Edward Greenleaf, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
294 ≥ 48th percentile 48% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Edward Greenleaf, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Edward Greenleaf, M.D.?
Quality data not reportedPrimary specialty
Radiation Oncology Physician
Medicare Part D claims
294 118% vs specialty avg
Specialty distribution in California
How Radiation Oncology Physician compares to other specialties among California providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Radiation Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1629158340 |
|---|---|
| Specialty | Radiation Oncology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 10/17/2006 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Edward Greenleaf, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$31
Largest payer
Merck Sharp & Dohme LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Edward Greenleaf, M.D.. To verify Edward Greenleaf, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
Edward Greenleaf, M.D. - brand share 7.0%
Radiation Oncology Physician average
7% brand-name claims vs 93% generic, on 294 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
294
Total Claims
$4K
Total Drug Cost
79
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 434.7
- Total Day Supply
- 10,397
- Brand vs Generic
- 7% brand / 93% generic
- Brand Drug Cost
- $678
- Generic Drug Cost
- $3K
- Opioid Claims
- 37 (12.6% rate)
- Antibiotic Claims
- 41
Patient Demographics
- Average Patient Age
- 73.1 years
- Avg HCC Risk Score
- 1.56
- Gender Split
- 38% female / 62% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Edward Greenleaf, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Tamsulosin Hcl
Tamsulosin Hcl
69 claims
- Ondansetron Hcl
Ondansetron Hcl
37 claims
- Hydrocodone-Acetam… 23
Hydrocodone-Acetaminophen
23 claims
- Bicalutamide 19
Bicalutamide
19 claims
- Cephalexin 15
Cephalexin
15 claims
- Ssd 15
Ssd
15 claims
- Lidocaine Hcl Visc… 12
Lidocaine Hcl Viscous
12 claims
| Drug | Claims |
|---|---|
| Tamsulosin Hcl | 69 |
| Ondansetron Hcl | 37 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 23 |
| Bicalutamide | 19 |
| Cephalexin | 15 |
| Ssd Silver Sulfadiazine | 15 |
| Lidocaine Hcl Viscous Lidocaine Hcl | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Radiation Oncology Physician Overview
How Edward Greenleaf, M.D. fits within the Radiation Oncology Physician landscape nationally.
6,141
Radiation Oncology Physician Providers in US
53
States with Radiation Oncology Physician
135
Avg Claims per Provider
Edward Greenleaf, M.D.'s 294 claims are above the specialty average of 135.
Nationwide Radiation Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Greenleaf, both outside California so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Radiation Oncology Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Greenleaf.
One of 643 Radiation Oncology Physician providers enrolled in California, 5 are shown here.
Christina Abel
NURSE PRACTITIONER
Orange, CA
Dr. Roy Abendroth
MD
San Francisco, CA
Dr. Sunil Advani
M.D.
La Jolla, CA
Dr. Faisal Ahmed
MD
Stanford, CA
Dr. Eugene Ahn
MD
Simi Valley, CA
Compare Radiation Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Edward Greenleaf, M.D.'s specialty? ▼
Edward Greenleaf, M.D. specializes in Radiation Oncology Physician and practices in Stockton, California. Credentials: M.D..
How much does Edward Greenleaf, M.D. prescribe under Medicare Part D? ▼
In 2024, Edward Greenleaf, M.D. wrote 294 Medicare Part D claims totaling $4K in drug costs for 79 beneficiaries.
Where is Edward Greenleaf, M.D. located? ▼
Edward Greenleaf, M.D. is located at 2027 GRAND CANAL BLVD STE 25, Stockton, CA, 95207. Phone: (209) 475-1111.
What is Edward Greenleaf, M.D.'s NPI number? ▼
Edward Greenleaf, M.D.'s National Provider Identifier (NPI) is 1629158340, issued on 10/17/2006.
Does Edward Greenleaf, M.D. prescribe more brand-name or generic drugs? ▼
Edward Greenleaf, M.D.'s prescribing is 7% brand-name and 93% generic drugs by claim count, with $678 in brand drug costs.
Does Edward Greenleaf, M.D. prescribe opioids? ▼
Yes, Edward Greenleaf, M.D. had 37 opioid claims in 2024 with an opioid prescribing rate of 12.6%.
How many Radiation Oncology Physician providers are there in the US? ▼
There are 6,141 Radiation Oncology Physician providers across 53 states in the US. The average Radiation Oncology Physician provider writes 135 Medicare Part D claims per year.
What drugs does Edward Greenleaf, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Edward Greenleaf, M.D.'s most frequently prescribed drugs include Tamsulosin Hcl, Ondansetron Hcl, Hydrocodone-Acetaminophen. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Edward Greenleaf, M.D. accept Medicare? ▼
Edward Greenleaf, M.D. appears in CMS Medicare data with 294 Part D claims and 79 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Edward Greenleaf, M.D.'s credentials? ▼
Edward Greenleaf, M.D.'s NPI is 1629158340 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.